Clinical utility of repurposing a short course of hepatitis C drugs for COVID19. A randomized controlled study
bioRxiv (2022) - Comments
doi: 10.1101/2022.07.18.22277477 

Mostafa Yakoot, Basem Eysa, Essam Gouda, Sherine A Helmy, Mahmoud R Elsayed, Ola Elrouby, Amal Mohamed, Ehab Reyad, Mohamed M Fawzi, Safaa Elmandouh, Wessam Abdellatif, Ahmed A Zidan, Abd-Elmoniem Adel, Mohamed Hassany